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Research Paper
Elevated blood pressure, heart rate and body temperature
in mice lacking the XLαs protein of the Gnas locus is due to
increased sympathetic tone
Nicolas Nunn1†, Claire H. Feetham2, Jennifer Martin1, Richard Barrett-Jolley2∗ and Antonius Plagge1∗
1Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
2Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK
New Findings
 What is the central question of this study?
Previously, we showed that Gnasxl knock-out mice are lean and hypermetabolic, with
increased sympathetic stimulation of adipose tissue. Do these mice also display elevated
sympathetic cardiovascular tone? Is the brain glucagon-like peptide-1 system involved?
 What is the main finding and its importance?
Gnasxl knock-outs have increased blood pressure, heart rate and body temperature. Heart
rate variability analysis suggests an elevated sympathetic tone. The sympatholytic reserpine
had stronger effects on blood pressure, heart rate and heart rate variability in knock-out
compared with wild-type mice. Stimulation of the glucagon-like peptide-1 system inhibited
parasympathetic tone to a similar extent in both genotypes, with a stronger associated increase
in heart rate in knock-outs. Deficiency of Gnasxl increases sympathetic cardiovascular tone.
Imbalances of energy homeostasis are often associated with cardiovascular complications.
Previouswork has shown thatGnasxl-deficientmice have a lean and hypermetabolic phenotype,
with increased sympathetic stimulation of adipose tissue. The Gnasxl transcript from the
imprinted Gnas locus encodes the trimeric G-protein subunit XLαs, which is expressed in
brain regions that regulate energy homeostasis and sympathetic nervous system (SNS) activity.
To determine whetherGnasxl knock-out (KO)mice display additional SNS-related phenotypes,
we have now investigated the cardiovascular system. The Gnasxl KO mice were ∼20mmHg
hypertensive in comparison to wild-type (WT) littermates (P ≤ 0.05) and hypersensitive to
the sympatholytic drug reserpine. Using telemetry, we detected an increased waking heart
rate in conscious KOs (630± 10 versus 584± 12 beats min−1, KO versus WT, P ≤ 0.05). Body
temperature was also elevated (38.1± 0.3 versus 36.9± 0.4◦C, KO versus WT, P ≤ 0.05). To
investigate autonomic nervous system influences, we used heart rate variability analyses.
We empirically defined frequency power bands using atropine and reserpine and verified
high-frequency (HF) power and low-frequency (LF) LF/HF power ratio to be indicators of
parasympathetic and sympathetic activity, respectively. The LF/HF power ratio was greater
in KOs and more sensitive to reserpine than in WTs, consistent with elevated SNS activity.
In contrast, atropine and exendin-4, a centrally acting agonist of the glucagon-like peptide-
1 receptor, which influences cardiovascular physiology and metabolism, reduced HF power
equally in both genotypes. This was associated with a greater increase in heart rate in KOs. Mild
stress had a blunted effect on the LF/HF ratio in KOs consistent with elevated basal sympathetic
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activity. We conclude that XLαs is required for the inhibition of sympathetic outflow towards
cardiovascular and metabolically relevant tissues.
(Received 18 March 2013; accepted after revision 6 June 2013; first published online 7 June 2013)
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It has been increasingly recognized over recent years that
disorders of energy balance and metabolism are often
associated with cardiovascular disease. Typically, these
symptoms occur jointly when central effects are involved.
Specifically, the sympathetic nervous system (SNS) has
been recognized as amajor regulator ofmetabolic rate and
cardiovascular physiology (Matsumura et al. 2003; Hall
et al. 2010; Malpas, 2010). Obesity-related cardiovascular
symptoms involve central actions of the adipokine leptin,
its downstream effector, the melanocortin system, and
subsequently increased sympathetic nerve activity (Hall
et al. 2010). Much less is known about cardiovascular
complications in disorders of hypermetabolism and
leanness. Genetic manipulations of the renin–angiotensin
system have been shown to increase metabolic rate
and affect blood pressure (BP) through central as
well as peripheral mechanisms (Dupont & Brouwers,
2010; Grobe et al. 2010). Another model with elevated
sympathetic and cardiovascular tone is the Schlager
inbred mouse line, which also displays reduced body
weight (Davern et al. 2009). However, the underlying
genetic cause for their phenotype is unknown. The
anatomical organization of brain regions involved in the
control of sympathetic activity is well known, although
any differential topographical regulation of SNS outflow
towards distinct peripheral tissues is less clear (Sved et al.
2001; Malpas, 2010; Nunn et al. 2011). Retrograde tracing
studies from various peripheral tissues have indicated a
common set of hierarchically organized brainstem and
hypothalamic areas to be involved in the control of SNS
outflow to diverse organs (Sved et al. 2001).
In this study, we analyse mice deficient for XLαs, a G-
protein α-subunit encoded by theGnasxl transcript of the
complexGnas locus (Plagge et al.2008).Gnasxl constitutes
an alternative splice variant of Gnas and differs only in
the NH2-terminal exon (Fig. S1). Like Gsα, XLαs links
a number of G-protein-coupled receptors in vitro, which
results in activation of adenylate cyclase and production of
cAMP (Liu et al. 2011). However, the specific receptor(s)
that signal through XLαs in vivo remain unknown. Gene
expression at the Gnas locus is regulated by the epigenetic
mechanism of ‘genomic imprinting’, which leads to the
silencing of one allele depending on its parental origin
(Plagge et al. 2008). Thus, Gnasxl expression occurs
exclusively from the paternal allele. By contrast, Gnas
remains expressed biallelically in most cells, with the
exception of some tissues where its expression is restricted
to the maternal allele, e.g. in the paraventricular nucleus
(PVN) of the hypothalamus (Fig. S1; Chen et al. 2009).
Loss of XLαs in mice results in a lean and hypermetabolic
phenotype, caused by increased sympathetic stimulation
of brown and white adipose tissues, and it has been
proposed that there may be a systemic increase in SNS
outflow (Xie et al. 2006). Expression of XLαs in adult mice
is limited almost exclusively to the brain and correlates
with SNS control centres, including the intermediolateral
layer (IML) of the spinal cord, the ventrolateral medulla,
medullary raphe nuclei, the nucleus tractus solitarii
(NTS), hypothalamic nuclei (PVN, dorsomedial nucleus,
lateral hypothalamic area, arcuate and suprachiasmatic
nuclei) and the preoptic area (Pasolli & Huttner, 2001;
Krechowec et al. 2012). Its expression in regions such as
the PVN and dorsomedial nucleus suggests that it may
influence wider sympathetic outflow, including targets
within the cardiovascular system (Coote, 2007; Womack
et al. 2007).
Here, we explore the cardiovascular phenotype of
Gnasxl knock-out (KO) mice and its regulation by the
autonomic nervous system. The effects of inhibition of
the sympathetic and parasympathetic nervous system
(PNS), respectively, were examined using reserpine, which
blocks the vesicular monoamine transporter at synapses,
and atropine, which inhibits muscarinic acetylcholine
receptors (Janssen et al. 2000; Young & Davisson, 2011).
To begin an investigation into potentially deregulated
neuropeptide systems that might be involved in the
Gnasxl KOphenotype,we explored responses to activation
of the brain glucagon-like peptide-1 (GLP-1) system.
Glucagon-like peptide-1, apart from its peripheral role,
also acts as a neuropeptide produced in the NTS of
the medulla (Llewellyn-Smith et al. 2011). As the GLP-
1 receptor signals via an α-stimulatory G-protein and
cAMP, this pathway could potentially be affected in
XLαs KO mice. Activation of the central GLP-1 receptor
has dual autonomic effects. It inhibits parasympathetic
control of the cardiovascular system, resulting in increased
heart rate (HR) and BP (Barragan et al. 1999; Yamamoto
et al. 2002; Hayes et al. 2008; Griffioen et al. 2011),
while it also stimulates sympathetic outflow towards
metabolically relevant tissues (Nogueiras et al. 2009).
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Furthermore, the c-fos response to the comparatively
stable GLP-1 receptor agonist exendin-4 (Ex-4), which
elicits identical central effects independent of its route
of injection (intraperitoneal or intracerebroventricular),
coincides with brain regions that control sympathetic
outflow in the hypothalamus, medulla and spinal cord
(Yamamoto et al. 2002; Baraboi et al. 2011).
In this study, we present BP and HR data obtained
from anaesthetized and conscious mice, respectively.
Autonomic influences onHRwere examined by heart rate
variability (HRV) analyses. Heart rate and HRV responses
to reserpine, atropine, Ex-4 and handling stress were
measured. Additionally, neuronal activation in response
to Ex-4 was quantified histologically via c-fos expression
analysis in wild-type (WT) and KO mice.
Methods
Ethical approval
All animal work was approved by the Ethical Review
Committee of the University of Liverpool and carried out
in accordancewith theUKAnimals (ScientificProcedures)
Act 1986 (UK Home Office Project Licences PPL40/3009
and PPL40/3351). All surgery was performed under
general anaesthesia as described in detail below.
Animals
Gnasxl mutant mice (Plagge et al. 2004) were maintained
on aCD1background.Gnasxl KOoffspring (Gnasxlm+/p−,
i.e. lacking XLαs expression from the paternally inherited
allele) were produced by mating CD1 females with Gnasxl
mutation-carryingmales.All experimentswereperformed
on young adult (∼4-month-old)maleGnasxl KO andWT
siblings.Mice weremaintained in the animal facility of the
University of Liverpool on a 12 h–12 h light–dark cycle and
had unlimited access to water and standard chow diet.
Blood pressure recordings and body temperature
measurements
For BP recordings via tail volume pressure recording
(VPR) plethysmography, which measures systolic and
diastolic pressure (CODA VPR system; Kent Scientific,
Torrington, CT, USA), mice were lightly anaesthetized
(urethane, 1.5 mg kg−1 I.P.; Sigma-Aldrich, UK) and
kept in thermoneutral conditions (ambient temperature
30◦C) throughout recording, which commonly results
in lower BP values compared with conscious mice at
room temperature (Swoap et al. 2004). A minimum of
10 readings were taken from each mouse; any values with
low (<15ml) displacement values were disregarded. For
BP recordings via cannulation, mice were anaesthetized
with urethane (1.4–2.2 mg kg−1) and α-chloralose (7–
11μg kg−1; Sigma-Aldrich, UK), administered I.P. in
saline; doses were matched within sibling groups. Body
temperature was recorded by rectal probe 3min after
injection of anaesthetic agents and prior to application
of external heat. After this, temperature was continuously
monitored and maintained at 37± 0.5◦C by heat pad and
infra-red lamp. Following loss of reflexes, the trachea was
intubated to facilitate breathing, and the carotid artery
was cannulated with stretched PP25 tubing filled with
heparinized saline, connected to a pressure transducer.
The raw blood pressure signal was digitized to a PC with
a CED Micro1401 (CED, Cambridge, UK) using Spike2
at 5 kHz. The raw signal was also split, AC coupled and
amplified between 10 and 100 times, depending on signal
strength, and recordedonSpike2at 5 kHz.Heartbeatswere
annotated to the amplified AC-coupled blood pressure
signal using Wabp from the Physionet suite of programs
(Goldberger et al. 2000). The numbers of animals used are
indicated in the Results section.
Telemetry surgery, recording and mild stress handling
Electrocardiogram transmitters (ETA-F20; Data Sciences
International, St Paul, MN, USA) were implanted
subcutaneously into adult mice under isoflurane–N2O
gas anaesthesia. The mice were given preoperative S.C.
injections of the analgesic buprenorphine (Temgesic,
1.5 mg kg−1; Reckitt Benckiser, Slough, UK), the
antibiotic enrofloxacin (Baytril, 0.2 ml kg−1; Bayer AG,
Leverkusen, Germany) and the anti-inflammatory
meloxicam (Metacam, 100μg kg−1; Boehringer
Ingelheim, Ingelheim, Germany). The mice were
monitored postoperatively, and were allowed at least
5 days of recovery before any further procedures were
begun. This recovery period was found to be sufficient for
the re-establishment of normalHRpatterns (Thireau et al.
2008); we observed no differences compared with data
from later time points. Mice were housed individually
over receiver pads (Data Sciences International); ECG
and locomotor activity were recorded continuously. The
ECG signal was digitized to a PC with a CED Micro1401
using Spike2 at 5 kHz; locomotor activity was recorded at
100 Hz. Heart rate and locomotor activity were annotated
using a custom program. Mild stress was induced by
handling of the mice (restrained by holding the scruff;
Meijer et al. 2006). Heart rate responses were evaluated
between 120 and 180min after reserpine injection, for
15min after stress, and between 60 and 120min after
injection of atropine and Ex-4. The numbers of animals
used are indicated in the Results section.
Heart rate variability
Heart rate variability analysis was performed using the
Kubios HRV program (Niskanen et al. 2004). For power
C© 2013 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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spectrum analysis, HR was resampled at 20 Hz, and 3min
sections of clean and stable HR were analysed by fast
Fourier transform using Welch’s periodogram with 50%
overlapping windows of 32 s. Low-frequency (LF) and
high-frequency (HF) bandings were 0.15–1.0 and 1.0–
5.0 Hz, respectively (see results for further details).
For analysis of HRV at night, a minimum of 10 3min
sections were selected for each mouse during a 5 h period
between 20.00 and 01.00 h. This period was chosen to
reflect the time of highest HR and activity (see Fig. 2A
and C).
Peripheral drug injections
Reserpine (Sigma-Aldrich, UK) was dissolved in 1%
acetic acid solution; it was injected at 2 mg kg−1 in
anaesthetized mice (cannulation experiments) and at
1 mg kg−1 in conscious mice (telemetry experiments).
Atropine (Sigma-Aldrich,UK) andEx-4 (Tocris,UK)were
dissolved in physiological saline (0.9%NaCl) and injected
at doses of 2 mg kg−1 and 50μg kg−1, respectively. All
injections were performed I.P. in 50μl volume.
c-fos immunostaining
Exendin-4 was injected I.P. at 50μg kg−1; 2 h later
mice were terminally anaesthetized with Pentobarbitone
(Pentoject, Animalcare, York, UK; 160mg kg−1 I.P.)
and perfused transcardially with 4% paraformaldehyde
in PBS. Tissues were removed, dehydrated with
30% sucrose in PBS and coronal cryostat sections
prepared. c-fos immunohistochemistry was performed
using rabbit anti-c-fos primary antibody (Ab5, 1:50,000
dilution; Calbiochem-Merck, Feltham, UK), followed
by signal amplification using the VECTASTAIN Elite
ABC kit (Vector Laboratories, Peterborough, UK) with
diaminobenzidine with 0.05% (w/v) NiCl2 substrate
(Sigma-Aldrich, UK). Immunofluorescence was used to
co-localize c-fos with XLαs onWT brain sections after Ex-
4 stimulation. The same c-fos primary antibody (1:2000
dilution)was combinedwithdonkey anti-rabbitAlexa 488
secondary antibody (1:1000 dilution; Life Technologies,
Paisley, UK); XLαs was detected using primary goat anti-
XLαs (sc-18993, 1:200 dilution; Santa Cruz, Heidelberg,
Germany) and donkey anti-goat Alexa 594 secondary
antibody (1:1000 dilution; Life Technologies). Tissues
from five WT and five KO mice were analysed.
Statistical analyses
For the measurements in anaesthetized dose-matched
siblings, Student’s paired t tests were used (Minitab
Ltd, Coventry, UK). Except where stated otherwise, the
telemetry data were analysed by Student’s unpaired t tests
or repeated-measures ANOVA (for circadian time points).
All graphs show data as means± SEM.
Results
Elevated BP in Gnasxl KO mice
Blood pressure was recorded from lightly anaesthetized
male Gnasxl KO mice and their WT littermates via tail
VPR plethysmography in thermoneutral conditions. We
found mean BP to be significantly higher in KO mice
than inWT siblings (Fig. 1A; 84± 6 versus 64± 4mmHg,
KO versus WT, P ≤ 0.05, n= 9 and 8). Responses to
the sympatholytic drug reserpine were recorded via
arterial cannulation, to allow continuous measurement
of BP. Knock-out mice had a significantly greater
response to reserpine than WT mice (Fig. 1B; −7± 1
versus −1± 2mmHg, KO versus WT, P ≤ 0.05, n= 5).
Responses to vehicle were similar in both genotypes
(data not shown). These findings suggest that elevated
sympathetic activity could be the underlying cause for the
increased BP in mutant mice. Additionally, and in line
with the previously described elevated energy expenditure
(Xie et al. 2006), KO mice had elevated body temperature
(Fig. 1C; 38.1± 0.3 versus 36.9± 0.4◦C, KO versus WT,
P ≤ 0.05, n= 7).
Figure 1. Blood pressure (BP), reserpine response and body
temperature in anaesthetized Gnasxl knock-out (KO) mice
A, mean basal BP (MAP) measured via tail volume pressure
recording plethysmography under light general anaesthesia
and thermoneutral conditions was significantly increased in KO
mice compared with wild-type (WT) mice (∗P ≤ 0.05, n = 9 and
8). The systolic and diastolic data for these mice are as follows:
systolic, WT 76.7 ± 5.1 mmHg versus KO 102.6 ± 6.4 mmHg,
P = 0.0072; and diastolic, WT 58.3 ± 4.2 mmHg versus KO
74.9 ± 6.4 mmHg, P = 0.053. B, the BP change in response to
reserpine was significantly greater in KO compared with WT
mice, relative to vehicle, as measured via arterial cannulation
(∗P ≤ 0.05, n = 5). C, KO mice had significantly elevated body
temperature as measured via rectal probe (∗P ≤ 0.05, n = 7).
Error bars indicate SEM.
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Increased basal HR in conscious Gnasxl KO mice
Heart rate data were obtained in anaesthesia-
free conditions following subcutaneous implantation
of telemetric transmitters. The ECG was recorded
continuously in freely moving mice, and HR was derived
using a custom program (see Fig. S2 for representative
telemetry data). Circadian variation in HR and locomotor
activity were plotted as averages per hour over a 24 h
period (Fig. 2A and C). Heart rate was found to be
Figure 2. Circadian heart rate (HR), activity and HR responses in conscious Gnasxl KO mice
Heart rate and activity were recorded continuously in freely moving KO mice and WT siblings via
ECG telemetry. A, 1 h averaged circadian HR over 24 h. Significantly different time points are indicated
(∗P ≤ 0.05, n = 12, repeated-measures ANOVA). Filled bar, night period; open bar, day period. B, mean
HR is increased at night in KO compared with WT mice (∗P ≤ 0.05), but did not reach significance during
the daytime. C, 1 h averaged circadian activity over 24 h. D, mean activity is unchanged in KO compared
withWTmice. E–G, treatments and HR recordings were undertaken during the light period. E, following
I.P. injection of 1 mg kg−1 of the sympatholytic reserpine the HR was significantly decreased in KO mice
and trended to be lower in WT mice. F, HR was significantly increased in KO mice following I.P. injection
of 2 mg kg−1 of the parasympatholytic atropine. G, HR was significantly increased, to a similar extent, in
both genotypes following mild handling stress. ∗P ≤ 0.05 by Student’s paired t test. Error bars indicate
SEM.
C© 2013 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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significantly higher in KO mice at several circadian time
points (Fig. 2A). Mean HR over 12 h day or night periods
was significantly increased in KO mice compared with
WTmice during the active night period (Fig. 2B; 630± 10
versus 584± 12 beats min−1, KO versus WT, P ≤ 0.05,
n= 12), while only a trend was observed during daytime.
However, no difference in locomotor activity between
genotypes was found (Fig. 2D).
Autonomic control of HR in conscious Gnasxl KO mice
The cause of the elevated HR in Gnasxl KO mice was
investigated by injection of reserpine and atropine to
inhibit sympathetic and parasympathetic stimulation,
respectively, of the cardiovascular system (Janssen et al.
2000; Young & Davisson, 2011). All treatments were
carried out during the daytime (light) period. Reserpine
at a dose of 1 mg kg−1 I.P. caused a significant decrease
in HR in KO mice (Fig. 2E; KO, from 531± 23 to
455± 12 beats min−1, P ≤ 0.05, n= 8; and WT, from
516± 21 to 471± 41 beats min−1, n.s., n= 8; Student’s
paired t test). Atropine at a dose of 2 mg kg−1 I.P. caused
a significant increase in HR in KO mice (Fig. 2F ; from
551± 16 to 591± 19 beats min−1, P ≤ 0.05, Student’s
paired t test,n= 6), but not inWTsiblings (from533± 28
to 552± 17 beats min−1, n= 6). These data, combined
with the HRV analysis described below, which shows the
effects of reserpine and atropine more clearly, suggest that
increased sympathetic tone causes elevated HR inGnasxl-
deficient mice and that inhibition of the parasympathetic
systememphasizes this effect.Additionally,we investigated
the cardiovascular reactivity of KO mice to mild handling
stress (Meijer et al. 2006). Heart rate increased to a similar
degree in response to stress inbothWTmice (Fig. 2G; from
568± 7 to 675± 39 beats min−1, P ≤ 0.05, n= 9) and KO
mice (from 615± 20 to 716± 11 beats min−1, P ≤ 0.05,
n= 9).
Analysis of HRV
In the context of abnormal HR phenotypes, HRV analysis,
especially the ratio of LF to HF HRV bandings, can
provide additional information on sympathetic versus
parasympathetic balance (Malpas, 2002; Baudrie et al.
2007; Laude et al. 2008; Thireau et al. 2008). We used
this approach via power spectrum analysis and tested
autonomic influences on the cardiovascular system in
conscious mice. The LF and HF HRV bandings were
validated empirically following inhibition of sympathetic
and parasympathetic cardiovascular tone of WT mice
with reserpine and atropine, respectively (Fig. S3). High-
frequency power was then used to indicate the degree of
parasympathetic stimulation of the cardiovascular system,
and the LF/HF ratio was used to indicate the degree
of sympathetic stimulation, specifically as a measure of
sympathovagal balance (Young & Davisson, 2011).
Autonomic control of HRV in conscious Gnasxl KO
mice was examined by measuring LF/HF responses to
reserpine, as well as HF power responses to atropine
during the day (light) period. The LF/HF ratio was
significantly reducedby reserpine inbothWTandKOmice
(Fig. 3A; WT, from 1.38± 0.31 to 0.47± 0.09, P ≤ 0.05;
and KO, from 1.39± 0.22 to 0.26± 0.06, P ≤ 0.05; both
by Student’s paired t test, n= 8). However, the decrease
in LF/HF ratio was significantly greater in KO compared
with WT mice (Fig. 3B; −80± 5 versus −48± 13%,
KO versus WT, P ≤ 0.05, n= 8). High-frequency power
was significantly reduced in response to atropine in
both WT and KO mice (Fig. 3C; WT, from 3.0± 0.6 to
1.2± 0.5 ms2 Hz−1, P ≤ 0.05; and KO, from 2.7± 0.7 to
0.6± 0.2 ms2 Hz−1, P ≤ 0.05; both by Student’s paired
t test, n= 6). There was no difference in HF power
decrease between WT and KO (Fig. 3D; −61± 16 versus
−77± 6% inWT versus KO, n= 6). Finally, with regard to
the stress response,meanLF/HF ratiowas increased inWT
(Fig. 3E; from 1.12± 0.15 to 1.85± 0.29, P ≤ 0.05, n= 8)
but not in KO mice (from 1.83± 0.46 to 1.62± 0.45),
whose basal LF/HF ratio was already as high as that of
the stressed WT siblings. The relative change in LF/HF
ratio was short of a significant difference between both
genotypes (Fig. 3F).
Having validated the effects of reserpine and atropine
on HRV of both genotypes, we investigated basal HRV
during the night phase, when HR and activity are highest.
Fast Fourier transform spectra were produced from a
minimum of 10 3min windows for each mouse as
discussed by Thireau et al. (2008; Fig. 4A). The Gnasxl
KO mice had an increased LF/HF ratio at night (Fig. 4B;
1.79± 0.18 versus 1.23± 0.14, KO versus WT, P ≤ 0.05,
n= 9 and 12), which is consistent with an elevated
sympathetic tone as themain cause of their cardiovascular
phenotype.
Cardiovascular responses to Ex-4
Given that the GLP-1 neuropeptide system impacts
on BP, HR and metabolic rate and that the GLP-1
receptor couples via an α-stimulatory G-protein, we
investigated this system using the agonist Ex-4. This
agonist elicits identical cardiovascular and brain c-fos
responses independent of its route of injection (Barragan
et al. 1999; Yamamoto et al. 2002; Hayes et al. 2008;
Nogueiras et al. 2009; Baraboi et al. 2011; Griffioen et al.
2011). First, the HR response to 50μg kg−1 Ex-4 was
examined (injected I.P. during the daytime); it resulted
in a significant increase in HR in KO mice (Fig. 5A
and B; from 542± 27 to 622± 14 beats min−1 in KO
C© 2013 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Figure 3. Heart rate variability (HRV) responses
Treatments and HR recordings by telemetry in conscious Gnasxl
KOs and WT siblings were carried out during the light period.
Low-frequency/high-frequency (LF/HF) ratio was used as an
indicator of sympathetic stimulation of the cardiovascular
system, specifically of sympathovagal balance, and HF power as
an indicator of parasympathetic stimulation. A, WT and KO
mice had a significant decrease in LF/HF ratio following I.P.
injection of 1 mg kg−1 reserpine. B, KO mice had a significantly
greater relative decrease in LF/HF ratio compared with WT mice.
C, both genotypes had a significant decrease in HF power
following I.P. injection of 2 mg kg−1 atropine. D, both
genotypes had a similar relative decrease in HF power. E, LF/HF
ratio was significantly increased in WT mice following stress,
but not in KO mice. F, the comparison between genotypes of
relative LF/HF change following stress did not reach
significance. ∗P ≤ 0.05 by Student’s paired t test, or by Student’s
unpaired t test in B. Error bars indicate SEM.
versus from 533± 21 to 561± 27 beats min−1 in WT;
P ≤ 0.05 by Student’s paired t test, n= 7). Heart rate
variability analysis indicated little effect on LF/HF ratio
(sympathetic stimulation) in WT or KO mice (Fig. 5C
and D). However, HF power (parasympathetic activity)
was decreased significantly by Ex-4 to a similar degree
in both genotypes (Fig. 5E and F ; WT, −76± 4%; and
KO, −77± 9%, P ≤ 0.001; both by Student’s paired t test,
n= 7), suggesting that the regulation of parasympathetic
tone by the GLP-1 system (Griffioen et al. 2011) is
functioningnormally in the absence ofXLαs. The effects of
Ex-4 were very similar to those of the parasympatholytic
atropine (Figs 2F and 3C and D). Both drugs caused a
similar HRV (HF) response in WT and KO mice, as well
as an increase in HR in KOs.
Neuronal c-fos responses to Ex-4
c-fos immunohistochemistry provides a useful
histological indicator of neuronal activation patterns
in response to various stimuli. In contrast, neuronal
inhibition does not result in c-fos induction (Dampney
& Horiuchi, 2003). We investigated potential changes in
the c-fos response to Ex-4 in Gnasxl KO mice using the
same dose as in the HR experiment. Exendin-4 resulted in
similar numbers of c-fos-positive neurons in the expected
brain regions (PVN, NTS, area postrema and amygdala)
in both genotypes (Fig. 6 and Figs S4 and S5). There was
also no difference in c-fos counts when a more detailed
analysis of PVN subregions along its rostral–caudal axis
was undertaken (data not shown). The unchanged c-fos
response in sympathetic control regions of XLαs-deficient
mice further supports the view that the functions of
the GLP-1 system are not impaired in KO mice. We
also examined whether the Ex-4-induced c-fos response
occurs in XLαs-expressing neurons in WT mice. There
was no overlap of expression of the two proteins in the
PVN or in the anterior part of the NTS, indicating that
XLαs-positive neurons are not activated by Ex-4 (Fig. 7
and Figs S6 and S7).
Discussion
In this study, we demonstrate, for the first time, that
Gnasxl-deficient mice have increased BP, HR and body
temperature, which is not associated with increased
locomotor activity. To examine the degree of sympathetic
stimulation of the cardiovascular system, mice were
injected with the sympatholytic reserpine, which inhibits
catecholamine uptake into secretory vesicles and thereby
release at sympathetic nerve terminals (Iversen et al. 1965).
Thus, it selectively diminishes sympathetic stimulation of
peripheral tissues. Reserpine caused a greater reduction in
BP,HR and LF/HF ratio ofHRV inKO comparedwithWT
C© 2013 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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mice, which concurs with the hypothesis of an increased
sympathetic stimulation of the cardiovascular system. In
contrast, inhibition of parasympathetic activity with the
muscarinic antagonist atropine (Janssen et al. 2000; Laude
et al. 2008; Young&Davisson, 2011) or theGLP-1 receptor
agonist Ex-4, which was only recently discovered to affect
parasympathetic cardiovascular control (Griffioen et al.
2011), caused similar reductions in HF power of HRV
in both WT and KO mice. This indicates normal levels
of parasympathetic tone in XLαs-deficient mice. The
increased HR in KO mice after atropine or Ex-4 injection
can be attributed to an underlying elevated basic level
of sympathetic activity in mutants compared with WT
mice.
For BP experiments, we chose an anaesthetic agent that
affects the cardiovascular system less thanother substances
(Carruba et al. 1987). Furthermore, the anaesthetic was
carefully dose matched among WT and KO littermate
groups, to equalize any effect. Thermoneutral conditions,
as used in our tail-cuff VPR experiment, also tend to lower
meanBP (Swoap et al. 2004).Nevertheless, we consistently
found BP and the reserpine-mediated reduction in BP
to be greater in Gnasxl KO mice. The cardiovascular
phenotype was further investigated in conscious, freely
movingmiceusing telemetry forECGmonitoring.Knock-
outmice showed an increasedHRmainly during the active
night period. The reserpine-mediated reduction in HR
of KO mice suggests increased sympathetic stimulation
of the cardiovascular system. Furthermore, a significant
increase in the HR of Gnasxl-deficient mice was observed
after application of themuscarinic blocker atropine. These
findings led us further to investigate HRV data, which
informon autonomic control of the cardiovascular system
and would exclude potential peripheral causes (Young &
Davisson, 2011).
Heart rate variability analysis is a method for
quantifying autonomic influences on the cardiovascular
system based on the inherent rhythms involved in
HR variation over time. These occur at characteristic
frequencies associated with SNS and PNS influences.
Heart rate variability is widely used as a helpful and
accurate indicator of autonomic balance (Baudrie et al.
2007; Laude et al.2008;Thireau et al.2008) andautonomic
responses (Farah et al. 2006; Griffioen et al. 2011). As
there are no universal HRV indicators that precisely
map to sympathetic activity (Malpas, 2002; Thireau et al.
2008), we defined these empirically by using the classical
sympatholytic and parasympatholytic drugs reserpine and
atropine, respectively (Iversen et al. 1965; Janssen et al.
2000; Laude et al. 2008; Young & Davisson, 2011). Our
empirical validation led us to set our HF band between
1 and 5 Hz. This is in agreement with other analyses
(Thireau et al. 2008). We determined that reserpine
resulted in loss of virtually all LF power density down
to 0.15 Hz. We therefore set our LF range between 0.15
and 1 Hz. In our verifications of drug effects on LF,
Figure 4. Basic HRV in conscious Gnasxl KO mice
Heart rate spectra were produced as in Fig. 3. A, typical HR spectra for WT (Aa) and KO mice (Ab).
B, LF/HF ratio was calculated for a minimum of 10 HR spectra for each mouse during the active dark
period; mean LF/HF ratio was increased in KO mice. ∗P ≤ 0.05, n = 9 and 12 for KO and WT, respectively.
Error bars indicate SEM.
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HF and the LF/HF ratio, atropine decreased LF and
HF but had minimal effect on the LF/HF ratio, whilst
reserpine decreased LF and the LF/HF ratio, without
significant change inHFpower. Therefore, the LF/HF ratio
appropriately indicates sympathetic tone.
Using these HRV bandings, we found that KO mice
had significantly increased LF/HF ratio during the active
night period. In KO mice, the LF/HF change after
reserpine was significantly more pronounced than in
WT mice, suggesting increased sympathetic tone. In
contrast, atropine induced a similar HF power response
in both genotypes, suggesting no difference in basal PNS
activity. The combined HRV and HR data after atropine
suppression of the PNS are consistent with elevated basal
SNS activity as the prominent cause of the cardiovascular
phenotype of Gnasxl KO mice.
Figure 5. Heart rate and HRV responses to exendin-4 (Ex-4)
Treatments and HR recordings were carried out during the light period as in Figs 2 and 3. A, HR response
over time in response to I.P. injection of 50 μg kg−1 Ex-4 (arrow). B, HR is significantly increased in KO
mice following Ex-4 and trended higher in WT mice. ∗∗P ≤ 0.01 by Student’s paired t test. C and D, there
was no significant difference in LF/HF ratio or relative change in LF/HF ratio following Ex-4 in either
genotype. E and F, both genotypes had a decrease in HF power following Ex-4, although this reached
significance only in WTs. The relative decrease in HF power was significant to a similar extent. ∗P ≤ 0.05
and ∗∗∗P ≤ 0.001 by Student’s paired t test. Error bars indicate SEM.
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Several neuropeptides have been shown to influence
the central control of the autonomic nervous system
and cardiovascular phenotype (Matsumura et al. 2003;
Dupont & Brouwers, 2010; Hall et al. 2010). To begin an
analysis of potentially deregulatedneuropeptide pathways,
which use α-stimulatory G-protein-coupled receptors for
signal transduction, we analysed the GLP-1 system. In
the CNS, GLP-1 is produced by neurons in the medulla
oblongata (Llewellyn-Smith et al. 2011). It increases
BP, HR and sympathetic outflow towards metabolically
Figure 6. Neuronal c-fos response to Ex-4 in the hypothalamic paraventricular nucleus (PVN)
c-fos immunohistochemistry of coronal brain sections after injection of 50 μg kg−1 I.P. Ex-4.
A, representative images showing high levels of c-fos in the PVN of both genotypes. B, no significant c-fos
response was observed following saline injection. C, there was no significant difference in numbers of c-
fos-positive neurones (per section and left/right brain side) between genotypes. This was also confirmed
in a more detailed anterior–posterior PVN subregion-specific assessment (data not shown). Error bars
indicate SEM.
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relevant tissues (Barragan et al. 1999; Yamamoto et al.
2002;Hayes et al. 2008;Nogueiras et al. 2009).Wedetected
an exaggerated HR response to Ex-4 in Gnasxl KO mice.
Our findings are consistent with a recent report on Ex-4-
induced changes in HR and in the HF component of HRV
(Griffioen et al. 2011). Together, these studies strongly
suggest that Ex-4 increases HR by suppressing cardiac
parasympathetic tone. Although Ex-4 reduced the HF
component of HRV to the same degree in WT and KO
mice, the increase in HR was more pronounced in XLαs-
deficient mice, which we attribute to a higher underlying
basal sympathetic tone.
In parallel to the suppression of parasympathetic
cardiovascular tone, the GLP-1 system also affects the SNS
and the hypothalamic–pituitary–adrenal axis (Gil-Lozano
et al. 2010). Exendin-4 induces c-fos expression inneurons
that project to the sympathetic preganglionic neurons
of the spinal cord, as well as in corticotropin-releasing
factor-positive neurons of the PVN (Yamamoto et al.
2002; Sarkar et al. 2003). It also stimulates sympathetic
nerve activity to white adipose tissue (Nogueiras
et al. 2009). A normal c-fos response and an unchanged
HRV LF/HF ratio in Gnasxl KO mice indicate that Ex-4
did not directly increase sympathetic stimulation of the
heart. It is also interesting to note that XLαs-positive
neurons did not show a c-fos response to Ex-4, which
concurs with previous findings that XLαs is expressed in
a neuron population different from, but in proximity to,
sympathetic control neurons at several levels of the CNS
(Krechowec et al. 2012).
Glucagon-like peptide-1 is not the only example
of a neuropeptide that regulates the PNS and
SNS reciprocally. A recent study showed that the
melanocortin peptide (α-MSH) system inhibits brainstem
parasympathetic preganglionic neurons, but activates
sympathetic preganglionic neurons in the spinal cord via
its MC4R receptor (Sohn et al. 2013). Stimulation of the
melanocortin system results in increased sympathetic tone
and hypertension (Hall et al. 2010; Sohn et al. 2013). As
the MC4R receptor signals through Gsα, the main protein
product of theGnas locus, there is an interesting antithesis
between the two splice variants XLαs and Gsα (Xie et al.
2006; Plagge et al. 2008; Chen et al. 2009; Sohn et al. 2013).
Knock-out mice for XLαs and Gsα, respectively, show
opposite physiological phenotypes.While XLαs deficiency
is associated with leanness and hypermetabolism (Xie
et al. 2006), lack of Gsα expression (from the maternal
allele, i.e. Gnasm−/p+) in the brain results in obesity and
hypometabolism (Chen et al. 2009). This Gsα-mutant
phenotype resembles MC4R deficiency (Balthasar et al.
2005).Brain-specificGnasm−/p+ mice are alsohypotensive,
with reduced HR and a global decrease in SNS activity
(Chen et al. 2009, 2012). In contrast, we show here
that Gnasxl KO mice are hypertensive and tachycardic
Figure 7. c-fos response to Ex-4 in correlation to XLαs expression in the PVN
Immunofluorescence for c-fos (green) and XLαs (red) on brain sections ofWTmice after Ex-4 I.P. injection.
A representative image demonstrates XLαs-expressing neurones located around the periphery of the
PVN, while all c-fos positive neurones are found in the centre of the PVN in a noticeably separate cell
population. Of five WT mice investigated, co-localization between XLαs and c-fos was <1%.
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due to increased sympathetic tone, which also causes
elevated energy expenditure (Xie et al. 2006). Whether
deficiency of XLαs might lead to an increased activity
of the melanocortin–MC4R–Gsα pathway remains to be
tested in future studies. It is also noteworthy that XLαs
and MC4R show a similar pattern of expression in some
subdivisions of the hypothalamic PVN (Kishi et al. 2003;
Liu et al. 2003; Krechowec et al. 2012). However, whether
coexpression occurs or whether separate neighbouring
neuron populations are involved remains to be
clarified.
The Gnasxl KO phenotype is also consistent with a
permanently activated stress reaction (Grippo et al. 2003;
Farah et al. 2006). We found that WT and KO mice had
comparable HR increases in response to stress, but the
increase in the LF/HF ratio of HRV seen in WT mice
was absent in KO mice. This would be consistent with a
model whereby the classic reduction in parasympathetic
cardiac inhibition by stress (Farah et al. 2006) still occurs,
but the sympathetic excitation does not increase further
in KOmice due to an already elevated basal cardiovascular
sympathetic tone.
In summary, our data indicate that Gnasxl KO
mice display a systemic increase in SNS activity, being
responsible for the cardiovascular as well as the metabolic
phenotype described previously (Xie et al. 2006). Our
findings imply that the in vivo role of XLαs involves
suppression of SNS outflow. This hypothesis is further
supported by the defined expression pattern of XLαs
in specific SNS control regions of the hypothalamus
and brainstem, including the PVN, dorsomedial nucleus,
lateral hypothalamic area, arcuate nucleus, medullary
raphe nuclei, NTS and spinal cord (Krechowec et al. 2012).
XLαs might, for example, mediate signal transduction
from a G-protein-coupled receptor(s) (Liu et al. 2011)
in a population of neurons that inhibits neighbouring
sympathetic control neurons. The nature of such a
receptor currently remains unclear, however. Future
experiments will be aimed at characterizing XLαs-
expressing neurons and the mechanisms by which
this protein inhibits sympathetic activity, including
analyses of additional neuroactive substances known
to function in XLαs-expressing brain regions, such
as α-MSH, angiotensin or substance P (Womack
& Barrett-Jolley, 2007; Womack et al. 2007; Nunn
et al. 2011).
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Figure S1. Simplified diagram of theGnas locus
Thematernal andpaternal alleles of the locus are indicated.
XLαs and the alternatively spliced Gsα are encoded by the
Gnasxl and Gnas transcripts, respectively. Both proteins
have a unique first exon, and share common downstream
exons. XLαs is expressed from the paternal allele (blue);
Gsα is expressed biallelically in most tissues, but in certain
cell types its expression is limited to the maternal allele
(red). The locus has been simplified to show only the two
major protein products of the locus, and is not to scale.
Figure S2. Typical ECG and HR traces in conscious
Gnasxl KOmice andWT siblings
A and B, ECG was recorded in conscious freely moving
adult KO mice B and WT siblings A. (i) Typical raw
ECG traces; (ii) high resolution region of ECG showing
annotated heart beats (red bars). (iii) Typical traces of
RR intervals and (iv) associated HR traces. (v) High
resolution HR traces showing substantial HRV over time.
These bandings were used for all the following HRV data
analyses. A, (i) Typical HR spectrum from a WT mouse
under basal conditions; (ii) typical spectrum following
loss of sympathetic stimulation after reserpine injection;
(iii) typical spectrum following loss of parasympathetic
stimulation after atropine injection. B, Both LF power
and LF/HF ratio were significantly reduced after reserpine
injection, with no significant change toHF power.C, Both
LFandHFpowerswere significantly reducedafter atropine
injection, with no significant change to LF/HF ratio. ∗P ≤
0.05 by paired t test. Error bars indicate SEM.
Figure S4. Neuronal c-fos responses to Ex-4 in the
amygdala
Gnasxl KOmice andWT siblingswere injectedwith 50μg/
kg I.P. Ex-4 and tissues collected two hours later. Brain
sections were stained for c-fos by immunohistochemistry.
A, Representative images showing c-fos response in the
amygdala of both genotypes. B, Representative images
showing no significant c-fos response in the same region
following saline injection. C, There was no significant
difference in numbers of c-fos positive neurones (per
section and left/right brain side) between genotypes. Error
bars indicate SEM.
Figure S5.Neuronal c-fos responses toEx-4 in the area
postrema (AP) andmedial region of the NTS
Gnasxl KOmice andWT siblingswere injectedwith 50μg/
kg I.P. Ex-4 and tissues collected two hours later. Brain
sections were stained for c-fos by immunohistochemistry.
A, Representative images showing c-fos response in
the AP and NTS of both genotypes. B, Representative
images showing no significant c-fos response in the same
brain regions following saline injection. C, There was
no significant difference in numbers of c-fos positive
neurones between genotypes. Error bars indicate SEM.
Figure S6. Control immunofluorescence forXLαs and
c-fos in response to Ex-4 in the hypothalamic PVN of
Gnasxl KO
Gnasxl KOmice were injected with 50 μg/kg I.P. Ex-4 and
tissues collected two hours later. Brain sections were co-
stained for c-fos (green) and XLαs (red). A representative
image is shown, demonstrating the specificity of the XLαs
antibody and a similar c-fos response as in WTs.
Figure S7. c-fos response to Ex-4 in XLαs-expressing
neurones of the amygdala
WT and KO mice were injected with 50 μg/kg I.P. Ex-
4 and tissues collected two hours later. Brain sections
were co-stained for c-fos (green) and XLαs (red).
A representative image is shown, demonstrating that
XLαs-expressing neurones and c-fos responsive neurones
constitute noticeably separate populations. Of 5 WTmice
investigated, there were no co-localised neurones found.
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